Clinical Outcomes of PIMSRA Treating for Hypertrophic Obstructive Cardiomyopathy: A Large-Sample Study

Active, not recruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

April 29, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Hypertrophic Obstructive Cardiomyopathy (HOCM)
Interventions
PROCEDURE

Percutaneous Intramyocardial Septal Radiofrequency Ablation

With the real-time guidance of TTE, a radiofrequency electrode needle was percutaneously inserted via the transapical intramyocardial approach into the hypertrophied septum for thermal ablation. Intraoperative TTE and 12-lead electrocardiographic monitoring were employed to assess the ablation extent and prevent vascular and cardiac conduction bundle injury. The success of ablation was confirmed by evaluating contrast medium perfusion defects in the ablated areas and comparing them with the preprocedural hypertrophied septum.

Trial Locations (1)

710032

Ultrasound Medicine Department of Xijing Hospital, Fourth Military Medical University, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER

NCT07003945 - Clinical Outcomes of PIMSRA Treating for Hypertrophic Obstructive Cardiomyopathy: A Large-Sample Study | Biotech Hunter | Biotech Hunter